Sequential hepatectomy for hepatocellular carcinoma with inadequate future-liver-remnant after portal vein ligation in combination with apatinib plus camrelizumab (PLACES): a single-arm prospective pilot study
PVL combined with apatinib and camrelizumab emerged as a promising therapy for HCC with inadequate FLR, demonstrating both efficacy and safety (chictr.org number, ChiCTR2000033692).
Authors
- Tianman Li
- Minhao Peng
- Hao Su (ORCID: https://orcid.org/0000-0002-7621-8730)
- Xiwen Liao (ORCID: https://orcid.org/0000-0002-1724-1463)
- Guangzhi Zhu (ORCID: https://orcid.org/0000-0001-5958-7289)
- Tao Peng (ORCID: https://orcid.org/0000-0001-6133-7078)
- Chuangye Han (ORCID: https://orcid.org/0000-0002-7670-4763)
- Ning Mo (ORCID: https://orcid.org/0000-0003-0786-1113)
- Cuizhen Liu
- Yanfeng Jiang (ORCID: https://orcid.org/0000-0002-5006-5190)
- Yongfei He (ORCID: https://orcid.org/0000-0001-8813-1416)
- Fuchao Ma
- Banghao Xu (ORCID: https://orcid.org/0000-0001-7270-3504)
- Ming Su (ORCID: https://orcid.org/0000-0002-0252-7936)
- J. Y. Liao (ORCID: https://orcid.org/0000-0001-8277-6133)
- Huasheng Huang (ORCID: https://orcid.org/0000-0001-8764-9264)
- Jie Ma (ORCID: https://orcid.org/0000-0001-5545-2651)
- Bin Chen (ORCID: https://orcid.org/0000-0003-0735-228X)
- Xinping Ye (ORCID: https://orcid.org/0000-0002-9200-1312)
- Xin Zhou (ORCID: https://orcid.org/0000-0003-2238-2890)
- Wen Zhang
- Jie Zeng (ORCID: https://orcid.org/0000-0002-8582-7319)
- Zhiming Zeng
- Wengang Luo
- Zili Lv (ORCID: https://orcid.org/0000-0001-9553-781X)
Institutions
- Guangxi Medical University (CN)
- Guangxi Science and Technology Department (CN)
- First Affiliated Hospital of GuangXi Medical University (CN)
- Tumor Hospital of Guangxi Medical University (CN)
Publication Details
- Journal
- HepatoBiliary Surgery and Nutrition
- Published
- 2025-03-11
- DOI
- https://doi.org/10.21037/hbsn-24-363
- Primary Topic
- Hepatocellular Carcinoma Treatment and Prognosis
- Type
- article
- Field-Weighted Citation Impact
- 0.00